A hybrid approach: a safe option for surgical treatment of early-stage cervical cancer.

Amengual Vila, J; Torrent Colomer, A; Sampol Bas, C; Quintero Duarte, A; Ruiz Coll, M; Rioja Merlo, J; Cordoba, O

Amengual Vila, J; Torrent Colomer, A; Sampol Bas, C; Quintero Duarte, A; Ruiz Coll, M; Rioja Merlo, J; Cordoba, O.

Affiliation

Amengual Vila J; Obstetrics and Gynecology Department, Gynecologic Oncology Unit, Hospital Universitari Son Espases, Palma, Spain. amengual.joana@gmail.com.

Eur Rev Med Pharmacol Sci ; 27(18): 8905-8914, 2023 09.

Article in En | MEDLINE | ID: mdl-37782199

Subject(s)

Lymphadenopathy; Uterine Cervical Neoplasms; Female; Humans; Adjuvants, Immunologic; Cognition; Drainage; Prospective Studies; Uterine Cervical Neoplasms/surgery

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Lymphadenopathy Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2023 Document type: Article Affiliation country: Spain Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google